Black Rock Inc. Arvinas, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Arvinas, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 6,258,808 shares of ARVN stock, worth $66.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,258,808
Previous 5,494,254
13.92%
Holding current value
$66.2 Million
Previous $227 Million
26.54%
% of portfolio
0.0%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding ARVN
# of Institutions
237Shares Held
65.2MCall Options Held
1.23MPut Options Held
372K-
Vanguard Group Inc Valley Forge, PA8.56MShares$90.5 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA5.58MShares$58.9 Million5.5% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.35MShares$35.4 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.13MShares$22.5 Million0.01% of portfolio
-
State Street Corp Boston, MA1.87MShares$19.8 Million0.0% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $562M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...